A detailed history of Dc Funds, LP transactions in Vaccitech PLC stock. As of the latest transaction made, Dc Funds, LP holds 642,204 shares of VACC stock, worth $2.19 Million. This represents 29.94% of its overall portfolio holdings.

Number of Shares
642,204
Previous 642,204 -0.0%
Holding current value
$2.19 Million
Previous $2.19 Million -0.0%
% of portfolio
29.94%
Previous 19.89%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 23, 2021

BUY
$13.03 - $17.0 $4.65 Million - $6.07 Million
357,204 Added 125.33%
642,204 $10.8 Million
Q2 2021

Aug 13, 2021

BUY
$13.03 - $17.0 $3.71 Million - $4.85 Million
285,000 New
285,000 $4.78 Million

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Dc Funds, LP Portfolio

Follow Dc Funds, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dc Funds, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dc Funds, LP with notifications on news.